Article
A compact glutamic acid decarboxylase 67 promoter enables inhibitory neuron-targeted AAV gene therapy for treatment-resistant epilepsy
2025-12-10
Abstract excerpt
<h4>ABSTRACT</h4> Epilepsy often becomes treatment-resistant, partly due to impaired inhibitory neurotransmission and reduced γ-aminobutyric acid (GABA) function. Enhancing inhibitory neuron activity via gene therapy may restore excitation–inhibition (E/I) balance. We developed a compact 410-bp glutamic acid decarboxylase 67 promoter (cmGAD67) that enables strong, selective transgene expression in inhibitory neur...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e428107f-8454-5b4b-b7b1-33764e85ee49
- DOI
- 10.64898/2025.12.07.692482
